Venrock Healthcare Capital Partners III, L.P. - 30 Sep 2025 SCHEDULE 13G/A Report for Tenax Therapeutics, Inc. Common Stock, $0.0001 par value per share (TENX)

Filing Manager: Venrock Healthcare Capital Partners III, L.P.
Reporting Manager: Venrock Healthcare Capital Partners III, L.P.
Security: Tenax Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol: TENX
Shares outstanding: 5,585,556 shares
Disclosed Ownership: 552,970 shares
Ownership: 9.9%
Form type: SCHEDULE 13G/A
Filing time: 14 Nov 2025, 17:38:40 UTC
Date of event: 30 Sep 2025
SEC: View on sec.gov

Reporting Managers (7)

Name	Ownership	Shares Owned	shared voting power	Signature	Title
Venrock Healthcare Capital Partners III, L.P.	9.9%	552,970	552,970	/s/ Sherman G. Souther	By VHCP Management III, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory
VHCP Co-Investment Holdings III, LLC	9.9%	552,970	552,970	/s/ Sherman G. Souther	By VHCP Management III, LLC, its Manager, By Sherman G. Souther, Authorized Signatory
Venrock Healthcare Capital Partners EG, L.P.	9.9%	552,970	552,970	/s/ Sherman G. Souther	By VHCP Management EG, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory
VHCP Management III, LLC	9.9%	552,970	552,970	/s/ Sherman G. Souther	By Sherman G. Souther, Authorized Signatory
VHCP Management EG, LLC	9.9%	552,970	552,970	/s/ Sherman G. Souther	By Sherman G. Souther, Authorized Signatory
Nimish Shah	9.9%	552,970	552,970	/s/ Sherman G. Souther	By Sherman G. Souther, Attorney-in-fact
Bong Y. Koh	9.9%	552,970	552,970	/s/ Sherman G. Souther	By Sherman G. Souther, Attorney-in-fact